VAGELOS P ROY - 03 Apr 2023 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
05 Apr 2023, 16:02:23 UTC
Prior SEC filing
27 Mar 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/**P. Roy Vagelos

Key filing fact

VAGELOS P ROY filed Form 4 for REGENERON PHARMACEUTICALS, INC. (REGN) on 05 Apr 2023.

Key facts

  • This page summarizes VAGELOS P ROY's Form 4 filing for REGENERON PHARMACEUTICALS, INC. (REGN).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 05 Apr 2023, 16:02.

Change

  • Previous filing in this sequence was filed on 27 Mar 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

REGN transaction

Common Stock

Gift

Transaction value
$0
Shares
-259
Change %
-0.21%
Price
$0.000000
Shares after
125,493
Date
03 Apr 2023
Ownership
by CLAT
REGN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
312,578
Date
03 Apr 2023
Ownership
Direct
REGN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,963
Date
03 Apr 2023
Ownership
By 401(k) Plan
REGN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
23,461
Date
03 Apr 2023
Ownership
by Spouse as Trustee
REGN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,609
Date
03 Apr 2023
Ownership
by trust for grandch
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

By trusts for the benefit of nine grandchildren of the reporting person, each of which holds 401 shares of Company stock. The reporting person and/or the spouse of the reporting person is the trustee of each such trust.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .